Consensus $131.45M. Cuts FY23 adjusted EBITDA view to loss of $76.9M from loss of $74.5M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PRCT:
- PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
- PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
- Wayfair upgraded, JD.com downgraded: Wall Street’s top analyst calls
- Procept BioRobotics initiated with an Outperform at Leerink
- Procept BioRobotics price target lowered to $37 from $49 at Truist
